XEPA SOUL PATTINSON MALAYSIA S.

Company Introduction: Xepa-Soul Pattinson (Malaysia) Sdn Bhd

Xepa-Soul Pattinson (Malaysia) Sdn Bhd is a prominent Malaysian pharmaceutical manufacturing company. Established in 1976, it operates as a wholly-owned subsidiary of Apex Healthcare Berhad, a company listed on Bursa Malaysia. Xepa-Soul Pattinson specializes in the research, development, manufacturing, and marketing of a wide array of pharmaceutical products. Their portfolio includes prescription medications, over-the-counter (OTC) drugs, and dietary supplements. The company maintains a modern manufacturing facility that adheres to stringent international Good Manufacturing Practice (GMP) standards, ensuring the production of high-quality and effective products. Xepa-Soul Pattinson is dedicated to enhancing public health by providing accessible and affordable medicines to patients within Malaysia and in its export markets.

This is a factory.

XEPA SOUL PATTINSON MALAYSIA S.B. manufactures and sells a wide range of pharmaceutical products. These products cover various therapeutic areas and include:

Respiratory medications such as cough and cold preparations, mucolytics, and bronchodilators.

Gastrointestinal medications including antacids, laxatives, and digestive aids.

Pain relievers and anti-inflammatory drugs for various types of pain and inflammation.

Dermatological products like creams, ointments, and lotions for skin conditions.

Anti-infectives, which encompass a variety of antibiotics, antifungals, and antivirals.

Vitamins and nutritional supplements to support overall health and address deficiencies.

Cardiovascular medications for conditions such as hypertension and hyperlipidemia.

Central Nervous System medications including anxiolytics and sedatives.

Ophthalmic preparations such such as eye drops for various eye conditions.

Urological medications for urinary tract health.

Many of their products are generic drugs, often marketed under their own brand names, frequently incorporating "Xepa" as a prefix.